bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet

RxCUI: 2283230
RxNorm name: bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet
Display name: bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet
Full name: bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Nexlizet	BEMPEDOIC ACID AND EZETIMIBE	Esperion Therapeutics, Inc.	3fa2108c-0300-47b8-9d34-f762af7c93c6	2026-06-25	Warnings, Adverse reactions	Exact identifier rxcui: 2283230

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
3fa2108c-0300-47b8-9d34-f762af7c93c6	bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet	SCD	22	These highlights do not include all the information needed to use NEXLIZET ® safely and effectively. See full prescribing information for NEXLIZET. NEXLIZET (bempedoic acid and ezetimibe) tablets, for oral use Initial U.S. Approval: 2020	20260115
3fa2108c-0300-47b8-9d34-f762af7c93c6	bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet	PSN	22	These highlights do not include all the information needed to use NEXLIZET ® safely and effectively. See full prescribing information for NEXLIZET. NEXLIZET (bempedoic acid and ezetimibe) tablets, for oral use Initial U.S. Approval: 2020	20260115